Extramedullary Waldenstrom macroglobulinemia

被引:61
作者
Banwait, Ranjit [1 ,2 ]
Aljawai, Yosra [1 ,2 ]
Cappuccio, Joseph [1 ,2 ]
McDiarmid, Serena [1 ,2 ]
Morgan, Elizabeth A. [2 ,3 ]
Leblebjian, Houry [1 ,2 ]
Roccaro, Aldo M. [1 ,2 ]
Laubach, Jacob [1 ,2 ]
Castillo, Jorge J. [1 ,2 ]
Paba-Prada, Claudia [1 ,2 ]
Treon, Steven [1 ,2 ]
Redd, Robert [2 ,4 ]
Weller, Edie [2 ,4 ]
Ghobrial, Irene M. [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Biostat & Computat, Boston, MA 02115 USA
关键词
CONSENSUS PANEL RECOMMENDATIONS; 2ND INTERNATIONAL WORKSHOP; MULTIPLE-MYELOMA; MYD88; L265P; CXCR4; MUTATIONS;
D O I
10.1002/ajh.23880
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disease assessment in Waldenstrom Macroglobulinemia (WM) is dependent on the percent involvement of B-cell neoplasm in the bone marrow and IgM paraprotein in the serum. A subset of patients also demonstrates extramedullary involvement, which is infrequently examined. The role of extramedullary involvement in the diagnosis and prognosis of WM is poorly understood. The purpose of this study is to report the characteristics of WM patients with extramedullary disease (EMD). Nine hundred and eight-five patients with WM were evaluated at one academic center and the presence of EMD was assessed in these patients. Forty-three (4.4%) patients were identified to have EMD. Nine (21%) patients presented with involvement at WM diagnosis, while 34 (79%) developed EMD post-therapy for WM. Most frequent EMD sites involved were pulmonary (30%), soft tissue (21%), cerebrospinal fluid (23%), renal (8%), and bone (9%). The median overall survival at 10 years was 79% (95% CI: 57-90%). This is the first study to describe the clinical characteristics, response and overall survival in patients with extramedullary WM. Further studies to define the molecular characteristics of this entity and mechanisms of its development are warranted. Am. J. Hematol. 90:100-104, 2015. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 28 条
[1]   Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma [J].
Alsayed, Yazan ;
Ngo, Hai ;
Runnels, Judith ;
Leleu, Xavier ;
Singha, Ujjal K. ;
Pitsillides, Costas M. ;
Spencer, Joel A. ;
Kimlinger, Teresa ;
Ghobrial, Joanna M. ;
Jia, Xiaoying ;
Lu, Ganwei ;
Timm, Michael ;
Kumar, Ashok ;
Cote, Daniel ;
Veilleux, Israel ;
Hedin, Karen E. ;
Roodman, G. David ;
WitZig, Thomas E. ;
Kung, Andrew L. ;
Hideshima, Teru ;
Anderson, Kenneth C. ;
Lin, Charles P. ;
Ghobrial, Irene M. .
BLOOD, 2007, 109 (07) :2708-2717
[2]   An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment [J].
Amin, CJ ;
Rabinowitz, I .
CLINICAL AND LABORATORY HAEMATOLOGY, 2005, 27 (03) :200-202
[3]   Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013 Featured Updates to the NCCN Guidelines [J].
Anderson, Kenneth C. ;
Alsina, Melissa ;
Bensinger, William ;
Biermann, J. Sybil ;
Cohen, Adam D. ;
Devine, Steven ;
Djulbegovic, Benjamin ;
Faber, Edward A., Jr. ;
Gasparetto, Christine ;
Hernandez-Ilizaliturri, Francisco ;
Huff, Carol Ann ;
Kassim, Adetola ;
Krishnan, Amrita Y. ;
Medeiros, Bruno C. ;
Meredith, Ruby ;
Raje, Noopur ;
Schriber, Jeffrey ;
Singhal, Seema ;
Somlo, George ;
Stockerl-Goldstein, Keith ;
Treon, Steven P. ;
Tricot, Guido ;
Weber, Donna M. ;
Yahalom, Joachim ;
Yunus, Furhan ;
Kumar, Rashmi ;
Shead, Dorothy A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (10) :1211-1219
[4]   Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features [J].
Azab, Abdel Kareem ;
Hu, Jinsong ;
Quang, Phong ;
Azab, Feda ;
Pitsillides, Costas ;
Awwad, Rana ;
Thompson, Brian ;
Maiso, Patricia ;
Sun, Jessica D. ;
Hart, Charles P. ;
Roccaro, Aldo M. ;
Sacco, Antonio ;
Ngo, Hai T. ;
Lin, Charles P. ;
Kung, Andrew L. ;
Carrasco, Ruben D. ;
Vanderkerken, Karin ;
Ghobrial, Irene M. .
BLOOD, 2012, 119 (24) :5782-5794
[5]   Heterogeneity of genomic evolution and mutational profiles in multiple myeloma [J].
Bolli, Niccolo ;
Avet-Loiseau, Herve ;
Wedge, David C. ;
Van Loo, Peter ;
Alexandrov, Ludmil B. ;
Martincorena, Inigo ;
Dawson, Kevin J. ;
Iorio, Francesco ;
Nik-Zainal, Serena ;
Bignell, Graham R. ;
Hinton, Jonathan W. ;
Li, Yilong ;
Tubio, Jose M. C. ;
McLaren, Stuart ;
Meara, Sarah O' ;
Butler, Adam P. ;
Teague, Jon W. ;
Mudie, Laura ;
Anderson, Elizabeth ;
Rashid, Naim ;
Tai, Yu-Tzu ;
Shammas, Masood A. ;
Sperling, Adam S. ;
Fulciniti, Mariateresa ;
Richardson, Paul G. ;
Parmigiani, Giovanni ;
Magrangeas, Florence ;
Minvielle, Stephane ;
Moreau, Philippe ;
Attal, Michel ;
Facon, Thierry ;
Futreal, P. Andrew ;
Anderson, Kenneth C. ;
Campbell, Peter J. ;
Munshi, Nikhil C. .
NATURE COMMUNICATIONS, 2014, 5
[6]   Schnitzler syndrome: Beyond the case reports: Review and follow-up of 94 patients with an emphasis on prognosis and treatment [J].
de Koning, Heleen D. ;
Bodar, Evelien J. ;
van der Meer, Jos W. M. ;
Simon, Anna .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2007, 37 (03) :137-148
[7]   Waldenstrom's macroglobulinemia: Clinical features, complications, and management [J].
Dimopoulos, MA ;
Panayiotidis, P ;
Moulopoulos, LA ;
Sfikakis, P ;
Dalakas, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :214-226
[8]   Update on Treatment Recommendations From the Fourth International Workshop on Waldenstrom's Macroglobulinemia [J].
Dimopoulos, Meletios Athanasios ;
Gertz, Morie A. ;
Kastritis, Efstathios ;
Garcia-Sanz, Ramon ;
Kimby, Eva K. ;
LeBlond, Veronique ;
Fermand, Jean-Paul ;
Merlini, Giampaolo ;
Morel, Pierre ;
Morra, Enrica ;
Ocio, Enrique M. ;
Owen, Roger ;
Ghobrial, Irene M. ;
Seymour, John ;
Kyle, Robert A. ;
Treon, Steven P. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) :120-126
[9]   Waldenstrom macroglobulinaemia [J].
Ghobrial, IM ;
Gertz, MA ;
Fonseca, R .
LANCET ONCOLOGY, 2003, 4 (11) :679-685
[10]  
HERRINTON LJ, 1993, BLOOD, V82, P3148